J&J/DePuy Projects SB Charite Artificial Lumbar Disc PMA Submission In 2004
This article was originally published in The Gray Sheet
Executive Summary
J&J/DePuy Acromed will establish itself as a player in the nascent artificial spinal disc market through the purchase of Link Spine Group for $325 mil., plus additional milestone payments
You may also be interested in...
J&J/DePuy Charite
Artificial spinal disc is on track for a U.S. debut in the first half of 2005 after J&J/DePuy's submission of a PMA application for the first-of-its-kind device Feb. 9. The filing includes data from a 375-patient, 15-center trial with two-year follow-up on 90% of patients. The study aimed to demonstrate equivalency to traditional spinal fusion. However, the firm claims that in many cases patients achieved superior outcomes with the artificial disc. J&J acquired the technology from Link Spine Group in May 2003 (1"The Gray Sheet" May 12, 2003, p. 22)...
J&J/DePuy Charite
Artificial spinal disc is on track for a U.S. debut in the first half of 2005 after J&J/DePuy's submission of a PMA application for the first-of-its-kind device Feb. 9. The filing includes data from a 375-patient, 15-center trial with two-year follow-up on 90% of patients. The study aimed to demonstrate equivalency to traditional spinal fusion. However, the firm claims that in many cases patients achieved superior outcomes with the artificial disc. J&J acquired the technology from Link Spine Group in May 2003 (1"The Gray Sheet" May 12, 2003, p. 22)...
Biomet Shooting For Hip, Knee, Shoulder Indications With Compress System
Biomet will seek additional indications later this year for its recently approved Compress distal femoral replacement system